It had already been observed in previous studies from our laboratory that heparanase-1 and heparanase-2 isoforms were overexpressed in the blood (mononuclear cell fraction) of women with breast cancer, thereby suggesting that this tumor can possibly modulate the expression of both heparanases.31 Here, HPSE2 is linked to breast cancer.